VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
ANIK
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
ANIKAnika Therapeutics, Inc.
$14.55$195M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksANIKQuarterly Financials

Anika Therapeutics, Inc. (ANIK) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Anika Therapeutics, Inc. (ANIK) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

ANIK Income Statement

Quarterly statement

ANIK Income Statement

Anika Therapeutics, Inc. (ANIK) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue30.59M32.61M29.61M30.61M27.82M28.22M26.17M-1.29M38.75M30.72M40.52M42.97M41.47M44.3M37.92M39.62M40.26M39.66M36.69M35.82M
Revenue Growth %9.98%15.56%13.16%2473.26%-28.22%-8.15%-35.42%-103%-6.54%-30.65%6.85%8.45%2.98%11.71%3.35%10.61%1.84%3.96%7%9.58%
Cost of Goods Sold11.76M11.37M10.62M11.44M12.23M13.86M11.49M-23.86M37.31M10.23M15.89M16.64M16.52M15.33M15.08M15.49M17.48M14.79M14.89M17.69M
COGS % of Revenue38.43%34.85%35.85%37.35%43.98%49.1%43.9%1849.22%96.28%33.31%39.22%38.73%39.84%34.6%39.77%39.1%43.43%37.31%40.58%49.38%
Gross Profit18.84M21.24M19M19.18M15.58M14.36M14.68M22.57M1.44M20.49M24.63M26.33M24.94M28.97M22.84M24.13M22.78M24.86M21.8M18.13M
Gross Margin %61.57%65.15%64.15%62.65%56.02%50.9%56.1%-1749.22%3.72%66.69%60.78%61.27%60.16%65.4%60.23%60.9%56.57%62.69%59.42%50.62%
Gross Profit Growth %20.87%47.91%29.4%-15.01%982.22%-29.9%-40.39%-14.3%-94.23%-29.28%7.81%9.11%9.5%16.53%4.77%33.07%-1.06%19.46%3.96%8.3%
Operating Expenses19.55M18.29M24.48M18.53M18.82M18.54M18.96M-5.25M29.46M22.3M29.69M90.11M32.62M32.6M35.4M30.8M28.58M28.24M25.36M27.26M
OpEx % of Revenue63.9%56.09%82.69%60.54%67.65%65.71%72.47%407.21%76.01%72.58%73.27%209.7%78.66%73.59%93.33%77.73%70.97%71.22%69.11%76.09%
Selling, General & Admin11.65M10.95M17.77M12.08M11.87M12.23M12.91M-4.89M19.11M15.62M21.53M20.34M24.83M23.69M27M23.05M21.28M21.27M19.2M20.43M
SG&A % of Revenue38.09%33.58%60.02%39.46%42.68%43.34%49.32%379.07%49.32%50.83%53.12%47.32%59.87%53.47%71.18%58.17%52.84%53.63%52.33%57.04%
Research & Development7.89M7.34M6.71M6.45M6.95M6.31M6.06M2.74M7.24M6.68M8.16M7.58M7.79M8.91M8.4M7.75M7.3M6.97M6.16M6M
R&D % of Revenue25.81%22.51%22.67%21.07%24.97%22.37%23.15%-212.25%18.69%21.75%20.15%17.65%18.79%20.12%22.15%19.56%18.13%17.59%16.78%16.75%
Other Operating Expenses0000000-1000K1000K001000K0000000825K
Operating Income-712K2.95M-5.49M646K-3.23M-4.18M-4.28M27.82M-28.02M-1.81M-5.06M-63.78M-7.67M-3.63M-12.55M-6.67M-5.8M-3.38M-3.55M-9.12M
Operating Margin %-2.33%9.06%-18.53%2.11%-11.62%-14.81%-16.37%-2156.43%-72.3%-5.89%-12.49%-148.43%-18.51%-8.2%-33.1%-16.83%-14.4%-8.53%-9.69%-25.47%
Operating Income Growth %77.98%170.67%-28.1%-97.68%88.46%-130.94%15.39%143.61%-265.09%50.15%59.67%-856.67%-32.36%-7.39%-253.21%26.92%-546%-136.83%-382.51%49.18%
EBITDA-712K4.46M-4.08M1.96M-1.83M-2.76M-2.69M29.63M-25.83M248K-2.46M-60.21M-4.13M-81K-9M-3M-2.3M328K63K-5.39M
EBITDA Margin %-2.33%13.67%-13.78%6.42%-6.58%-9.79%-10.29%-2296.9%-66.65%0.81%-6.08%-140.11%-9.96%-0.18%-23.74%-7.57%-5.72%0.83%0.17%-15.06%
EBITDA Growth %61.09%261.32%-51.6%-93.37%92.91%-1214.52%-9.25%149.21%-525.1%406.17%72.63%-1906.23%-79.42%-124.7%-14388.89%44.35%-147.23%-97.41%-98.68%62.68%
D&A (Non-Cash Add-back)01.5M1.41M1.32M1.4M1.42M1.59M1.81M2.19M2.06M2.6M3.57M3.54M3.55M3.55M3.67M3.5M3.71M3.62M3.73M
EBIT03.38M-4.82M764K-2.24M-3.97M-3.87M24.72M-27.61M-1.22M-4.47M-1.59M-7.67M-3.63M-12.55M-6.67M-5.8M-3.38M-3.55M-8.3M
Net Interest Income0426K000214K00406K595K0577K635K0539K000-154K-47K
Interest Income0426K000214K00406K595K-577K635K0539K00-00
Interest Expense390K000000000-000000-154K47K
Other Income/Expense390K426K667K118K997K214K415K744K406K595K592K577K635K561K539K276K436K96K-154K-47K
Pretax Income-322K3.38M-4.82M764K-2.24M-3.97M-3.87M28.56M-27.61M-1.22M-4.47M-63.2M-7.04M-3.07M-12.01M-6.39M-5.36M-3.29M-3.71M-9.17M
Pretax Margin %-1.05%10.36%-16.28%2.5%-8.04%-14.05%-14.79%-2214.11%-71.25%-3.95%-11.03%-147.09%-16.98%-6.93%-31.68%-16.13%-13.32%-8.28%-10.11%-25.6%
Income Tax-11K71K235K-1.04M939K681K89K2.87M2.31M1.33M43K-204K-463K-329K-1.66M-1.48M-1.19M-442K-775K-3.38M
Effective Tax Rate %3.42%2.1%-4.87%-135.73%-41.99%-17.17%-2.3%10.05%-8.36%-109.14%-0.96%0.32%6.58%10.72%13.85%23.2%22.14%13.46%20.9%36.83%
Net Income-311K3.31M-5.06M292K-2.33M-3.97M-4.87M-21.86M-29.92M-88K-4.51M-63M-6.58M-2.74M-10.35M-4.91M-4.17M-2.84M-2.93M-5.79M
Net Margin %-1.02%10.15%-17.07%0.95%-8.37%-14.07%-18.62%1694.96%-77.2%-0.29%-11.14%-146.61%-15.86%-6.19%-27.29%-12.39%-10.37%-7.17%-7.99%-16.17%
Net Income Growth %86.65%183.35%-3.76%101.34%92.22%-4411.36%-7.95%65.29%-354.96%96.79%56.39%-1183.62%-57.51%3.59%-252.88%15.28%-848.21%-143.53%-203.35%63%
Net Income (Continuing)-311K3.31M-5.06M1.8M-3.17M-4.65M-3.96M25.69M-29.92M-2.54M-4.51M-63M-6.58M-2.74M-10.35M-4.91M-4.17M-2.84M-2.93M-5.79M
Discontinued Operations000-1000K846K677K-915K001000K0000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.020.24-0.370.02-0.16-0.28-0.34-1.50-2.03-0.01-0.31-4.30-0.45-0.19-0.71-0.34-0.29-0.20-0.20-0.40
EPS Growth %85.5%185.71%-8.82%101.33%92.12%--9.68%65.12%-351.11%96.89%56.34%-1164.71%-55.17%5%-255%15%-825%-144.44%-200%63.64%
EPS (Basic)-0.020.24-0.370.02-0.16-0.28-0.34-1.50-2.03-0.01-0.31-4.30-0.45-0.19-0.71-0.34-0.29-0.20-0.20-0.40
Diluted Shares Outstanding13.39M13.43M13.53M14.67M14.42M14.36M14.3M14.72M14.77M14.84M14.7M14.65M14.63M14.69M14.65M14.64M14.6M14.55M14.47M14.44M
Basic Shares Outstanding13.39M13.43M13.53M14.27M14.42M14.36M14.3M14.58M14.77M14.84M14.7M14.65M14.63M14.69M14.58M14.64M14.4M14.21M14.47M14.37M
Dividend Payout Ratio--------------------